Neptune Appoints John Moretz as Special Advisor and Nominee to Its Board of Directors
18 févr. 2014 07h50 HE
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Feb. 18, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) announces the appointment of John Moretz as...
Neptune and Acasti Provide Update on Patent Litigations With Enzymotec
14 févr. 2014 09h52 HE
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Feb. 14, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) and Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a...
Neptune Reports Third Quarter Results and Provides Update on Action Plan to Resume Operations
14 janv. 2014 07h30 HE
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Jan. 14, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) announces its consolidated financial results for...
Neptune Receives New Food Raw Material Certification in China
09 janv. 2014 07h30 HE
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Jan. 9, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) announces that it has received "New Food Raw...
Neptune to Hold Conference Call to Discuss Third Quarter Results
07 janv. 2014 07h30 HE
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) will be holding a conference call on Wednesday January 15, at 9:00 am...
Neptune Appoints Jerald J. Wenker as Special Advisor and Nominee to Its Board of Directors
19 déc. 2013 07h30 HE
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Dec. 19, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) announces the appointment of Jerald J. Wenker as...
Neptune, Acasti and Enzymotec Sign Settlement Term Sheet Resulting in Stay of ITC Investigation for 30 Days
18 déc. 2013 08h58 HE
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Dec. 18, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) and Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a...
Neptune and Aker BioMarine Reach Patent Infringement Settlement and License Agreement
17 déc. 2013 08h30 HE
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Dec. 17, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB), Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a Neptune...
Neptune Participates in the Equity Financing of Acasti Pharma
03 déc. 2013 15h13 HE
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Dec. 3, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) announces that it acquired securities of its...
Neptune Reaffirms Its Patent Position
12 nov. 2013 08h05 HE
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Nov. 12, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) announces that one of its competitors, Aker...